ES2234914T3 - Intermediarios utiles para la sintesis de retinoides. - Google Patents

Intermediarios utiles para la sintesis de retinoides.

Info

Publication number
ES2234914T3
ES2234914T3 ES01983636T ES01983636T ES2234914T3 ES 2234914 T3 ES2234914 T3 ES 2234914T3 ES 01983636 T ES01983636 T ES 01983636T ES 01983636 T ES01983636 T ES 01983636T ES 2234914 T3 ES2234914 T3 ES 2234914T3
Authority
ES
Spain
Prior art keywords
carbon atoms
group
different
branched
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01983636T
Other languages
English (en)
Inventor
Alain Valla
Dominique Cartier
Roger Labia
Pierre Jean-Paul Potier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of ES2234914T3 publication Critical patent/ES2234914T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/10—Formation of amino groups in compounds containing carboxyl groups with simultaneously increasing the number of carbon atoms in the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/14—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/14—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by doubly-bound oxygen atoms
    • C07C403/16—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by doubly-bound oxygen atoms not being part of —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/313—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Physical Vapour Deposition (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Compuestos de fórmula (1) en la que - G representa un grupo ¿NR4R5 en el que R4 y R5, idénticos o diferentes, son cada uno un grupo alquilo de 1 a 5 átomos de carbono, lineal o ramificado, o un grupo cicloalquilo de 3 a 7 átomos de carbono, o R4 y R5 forman un ciclo con el átomo de nitrógeno que los contiene, - R1 representa, o bien un átomo de hidrógeno, o bien un grupo alquilo de 1 a 5 átomos de carbono, lineal o ramificado, - n es un número entero comprendido entre 1 y 2, - R2 y R3 representan un sustituyente similar o diferente en cada uno de los motivos insaturados, pudiendo dichos motivos insaturados sucesivos, ser por otra parte, idénticos o diferentes, siendo R2 y R3 seleccionados de entre el grupo que comprende hidrógeno, y los grupos alquilo de 1 a 5 átomos de carbono, lineales o ramificados, y con la condición de que al menos uno de los sustituyentes R1, R2 y R3 sea diferente de H, y - Y1 e Y2 representan cada uno un grupo ¿COOR7 en el que R7 es un grupo alquilo de 1 a 5 átomos de carbono.
ES01983636T 2000-10-26 2001-10-26 Intermediarios utiles para la sintesis de retinoides. Expired - Lifetime ES2234914T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0013726A FR2815961B1 (fr) 2000-10-26 2000-10-26 Nouveaux intermediaires utiles pour la synthese de retinoides

Publications (1)

Publication Number Publication Date
ES2234914T3 true ES2234914T3 (es) 2005-07-01

Family

ID=8855754

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01983636T Expired - Lifetime ES2234914T3 (es) 2000-10-26 2001-10-26 Intermediarios utiles para la sintesis de retinoides.

Country Status (9)

Country Link
US (3) US7009069B2 (es)
EP (1) EP1328506B1 (es)
JP (1) JP4334868B2 (es)
AT (1) ATE286017T1 (es)
CA (1) CA2427043C (es)
DE (1) DE60108153T2 (es)
ES (1) ES2234914T3 (es)
FR (1) FR2815961B1 (es)
WO (1) WO2002034710A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2416351A (en) * 2004-06-29 2006-01-25 Ciba Sc Holding Ag Use of myocyanine derivatives for the protection of human hair and skin from UV radiation
JP4864623B2 (ja) * 2006-09-27 2012-02-01 富士フイルム株式会社 δ−アミノペンタジエン酸エステル誘導体の製造方法
GB2445635A (en) * 2006-10-13 2008-07-16 Ciba Sc Holding Ag Merocyanine derivatives useful as UV absorbers
DE102008002302A1 (de) 2007-06-13 2008-12-18 Basf Se Verfahren zur Hestellung von Etretinat
US8158964B2 (en) * 2009-07-13 2012-04-17 Seagate Technology Llc Schottky diode switch and memory units containing the same
BR112014001418B1 (pt) 2011-07-21 2021-05-11 Basf Se compostos, e, processo para a preparação dos compostos
WO2013010590A1 (en) 2011-07-21 2013-01-24 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
FR3001133B1 (fr) 2013-01-21 2015-03-20 Oreal Composition cosmetique ou dermatologique comprenant une merocyanine et une phase huileuse comprenant au moins un compose amide particulier
FR3001138B1 (fr) 2013-01-21 2015-06-19 Oreal Composition anhydre cosmetique ou dermatologique comprenant une merocyanine et une phase huileuse
FR3001216B1 (fr) 2013-01-21 2015-02-27 Oreal Composition cosmetique ou dermatologique comprenant une merocyanine, une phase huileuse et un mono-alcanol en c1-c4
FR3046930B1 (fr) 2016-01-26 2018-03-02 L'oreal Composition cosmetique ou dermatologique comprenant une merocyanine et une phase huileuse comprenant au moins un polyalkyleneglycol
FR3046927B1 (fr) 2016-01-26 2018-03-02 L'oreal Composition cosmetique ou dermatologique comprenant une merocyanine et une phase huileuse comprenant au moins un ether d'isosorbide
FR3046929B1 (fr) 2016-01-26 2018-03-02 L'oreal Composition cosmetique ou dermatologique comprenant une merocyanine et une phase huileuse comprenant au moins un ester d'acide di ou tricarboxylique
FR3046928B1 (fr) 2016-01-26 2019-08-09 L'oreal Composition cosmetique ou dermatologique comprenant une merocyanine et une phase huileuse comprenant au moins un amide n-substitue
FR3083097B1 (fr) 2018-06-28 2020-11-27 Oreal Composition cosmetique ou dermatologique comprenant une merocyanine et une phase huileuse comprenant au moins un carbonate d’alkyle ou d’alkylene
FR3117825B1 (fr) 2020-12-18 2026-02-20 Oreal Composition cosmétique ou dermatologique comprenant une mérocyanine, un filtre UV triazine, et un polysaccharide modifié par des chaînes hydrophobes
FR3117824B1 (fr) 2020-12-18 2026-02-06 Oreal Composition cosmétique ou dermatologique comprenant une mérocyanine et une phase huileuse comprenant au moins un ester d’acide citrique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1055849A (fr) * 1950-04-22 1954-02-22 Eastman Kodak Co Nouveau procédé de synthèse de polyènes caroténoïdes
DE1046612B (de) * 1957-10-23 1958-12-18 Basf Ag Verfahren zur Herstellung von Vitamin A und seinen biologisch wirksamen Derivaten
DE1059900B (de) * 1957-09-03 1959-06-25 Basf Ag Verfahren zur Herstellung von Verbindungen der Vitamin A-Reihe
DE1559900A1 (de) 1966-11-09 1970-03-05 Hettich Paul & Co Unsichtbares Scharnier
JPS53128333A (en) 1977-04-15 1978-11-09 Fuji Photo Film Co Ltd Prevention of influences of ultraviolet ray upon photosensitive material of silver halogenide
FR2728260B1 (fr) * 1994-12-16 1997-03-14 Centre Nat Rech Scient Beta-methylene aldehydes utiles notamment pour la preparation de composes d'interet tels que les retinoides ou les carotenoides et preparation de composes d'interet au moyen desdits beta-methylene aldehydes

Also Published As

Publication number Publication date
ATE286017T1 (de) 2005-01-15
EP1328506A2 (fr) 2003-07-23
CA2427043C (fr) 2012-12-04
US20040132796A1 (en) 2004-07-08
WO2002034710A3 (fr) 2002-07-04
US7323589B2 (en) 2008-01-29
EP1328506B1 (fr) 2004-12-29
FR2815961B1 (fr) 2008-11-28
DE60108153T2 (de) 2005-12-08
JP4334868B2 (ja) 2009-09-30
US20060106245A1 (en) 2006-05-18
US20060135808A1 (en) 2006-06-22
FR2815961A1 (fr) 2002-05-03
US7009069B2 (en) 2006-03-07
JP2004530636A (ja) 2004-10-07
US7148372B2 (en) 2006-12-12
DE60108153D1 (de) 2005-02-03
CA2427043A1 (fr) 2002-05-02
WO2002034710A2 (fr) 2002-05-02

Similar Documents

Publication Publication Date Title
ES2184686T3 (es) Composicion que comprende un compuesto derivado de ciclohexano, compuesto y utilizacion de dicho compuesto para estructurar una composicion.
CO5180537A1 (es) Nuevos derivados de hexa-, penta- y tetra-peptidos como inhibidores de la hepatitis c. comprendiendo sus racematos, diastereoisomeros e isomeros opticos y procedimiento para la preparacion de los mismos
AR041867A1 (es) Agente para prevenir o tratar neuropatia
MXPA05010638A (es) Aditivo para cemento.
CO4700523A1 (es) Purin-6-onas bisustituidas en 2,9
HRP20021038B1 (hr) Spojevi sa sulfonamidnom grupom i farmaceutske smjese koje sadrže te spojeve
CO5700820A2 (es) Derivados de dioxan-2-alquilcarbamatos, su preparacion y su aplicacion en terapeutica
MX174129B (es) Procedimiento para la preparacion de nuevos 19-nor-esteroides sustituidos en la posicion 7 y producto obtenido
CO4900071A1 (es) Derivados de pirido [4´, 3´:4,5] tieno (2,3- d) pirimidina sustituidos en posicion 3
DOP2006000045A (es) Derivados del (1,5-difenil-1h-pirazol-3-il oxadiazol, su preparacion y su aplicacion en terapeutica
ES457768A1 (es) Procedimiento para estabilizar resinas que contienen cloro.
SE7710395L (sv) Bekempningsmedel mot skadegorare
ATE422163T1 (de) Absorbierbare alpha-cyanacrylat-zusammensetzungen
CO5550494A2 (es) Derivados de diamina, proceso para producir los derivados de diamina, y fungicidas que contienen los derivados de diamina como ingrediente activo
TW200706694A (en) Water-soluble preflux and use thereof
CO6180444A2 (es) Marcacion con fluor radioactivo
CO5690608A2 (es) 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogena cronica
CO5611109A2 (es) Combinaciones de un ligando alfa-2-delta con un inhibidor selectivo de la ciclooxigenasa-2
DK1485625T3 (da) Radioisotopgenerator omfattende én eller flere elementstøtter
EP0728763A4 (en) GANGLIOSIDE GM3 ANALOG COMPRISING A RESIDUE OF FLUORINATED SIALIC ACID IN POSITION 9, AND INTERMEDIATE NECESSARY
BR0115616A (pt) Preparação de inibidores de permutadores sódio-hidrogênio do tipo 1
CO5170535A1 (es) Derivados de n-[2-(4-aminofenil)etil]2,3-dihidro-1,4- benzodioxin-2-metanamina, su preparacion y su aplciacion en terapeutica
ES2172967T3 (es) Metilciclotetradec-5-en-1-ona.
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
DE602006019474D1 (de) Hren dafür und verwendungen davon